Journal Of Child And Adolescent Psychopharmacology

Journal Title：Journal Of Child And Adolescent Psychopharmacology

Journal of Child and Adolescent Psychopharmacology (JCAP) is the premier peer-reviewed journal covering the clinical aspects of treating this patient population with psychotropic medications including side effects and interactions, standard doses, and research on new and existing medications. The Journal includes information on related areas of medical sciences such as advances in developmental pharmacokinetics, developmental neuroscience, metabolism, nutrition, molecular genetics, and more.

Journal of Child and Adolescent Psychopharmacology coverage includes:

New drugs and treatment strategies including the use of psycho-stimulants, selective serotonin reuptake inhibitors, mood stabilizers, and atypical antipsychotics

New developments in the diagnosis and treatment of ADHD, anxiety disorders, schizophrenia, autism spectrum disorders, bipolar disorder, eating disorders, along with other disorders

Reports of common and rare Treatment Emergent Adverse Events (TEAEs) including: hyperprolactinemia, galactorrhea, weight gain/loss, metabolic syndrome, dyslipidemia, switching phenomena, sudden death, and the potential increase of suicide. Outcomes research.

《儿童与青少年精神药理学杂志》（JCAP）是首屈一指的同行评审期刊，涵盖使用精神药物治疗该患者群体的临床方面，包括副作用和相互作用、标准剂量以及对新药物和现有药物的研究。该期刊包含有关医学科学相关领域的信息，例如发育药代动力学、发育神经科学、代谢、营养、分子遗传学等方面的进展。

《儿童和青少年精神药理学杂志》的报道包括：

新药和治疗策略，包括使用精神兴奋剂、选择性血清素再摄取抑制剂、情绪稳定剂和非典型抗精神病药

多动症、焦虑症、精神分裂症、自闭症谱系障碍、双相情感障碍、饮食失调以及其他疾病的诊断和治疗的新进展

常见和罕见的治疗突发不良事件 (TEAE) 报告，包括：高催乳素血症、溢乳、体重增加/减少、代谢综合征、血脂异常、转换现象、猝死和自杀的潜在增加。结果研究。

Journal Of Child And Adolescent Psychopharmacology创刊于1990年，由Mary Ann Liebert Inc.出版商出版，收稿方向涵盖医学 - 精神病学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 12周，或约稿 ，影响因子指数1.5，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。